Colin Hill
CIK: 0001673192
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FULC
Fulcrum Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Hill Colin
Hill Colin (SEC CIK 0001673192) files insider reports with the SEC as Director of Fulcrum Therapeutics, Inc. (FULC).
Signal8 holds 2 ownership filings by Hill Colin, all Form 4s, filed between Jun 30, 2025 and Jul 2, 2026. Those filings report 2 transactions, from Jun 26, 2025 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hill Colin's filings is in CAMBRIDGE, MA.
Recent filings by Hill Colin
Other insiders filing for Fulcrum Therapeutics, Inc. (FULC)
- TANG KEVIN, 10% Owner
- Banks Sonja, Director
- Dorton Katina, Director
- Gould Robert J, Director
- Haviland Kate, Director
- King Rachel K., Director